|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable: | ||||||||||||||||||||
| Joint owners, net | ||||||||||||||||||||
| Oil and gas production sales | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Total accounts receivable | ||||||||||||||||||||
| Derivative asset - short-term | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment | ||||||||||||||||||||
| Proved oil and gas properties, full cost method | ||||||||||||||||||||
| Other property and equipment | ||||||||||||||||||||
| Total | ||||||||||||||||||||
| Less accumulated depreciation, depletion, amortization and impairment | ||||||||||||||||||||
| Total property and equipment - net | ||||||||||||||||||||
| Investment in partnership | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Derivative asset, long-term | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Joint interest oil and gas production payable | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Other accrued liabilities | ||||||||||||||||||||
| Derivative liability, current | ||||||||||||||||||||
| Termination of derivative contracts | ||||||||||||||||||||
| Right of use liability | ||||||||||||||||||||
| Current maturities of long-term debt | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt - less current maturities | ||||||||||||||||||||
| Debt Instruments Excluding PPP Loan | ||||||||||||||||||||
| Paycheck Protection Program, CARES Act | ||||||||||||||||||||
| Total long-term debt - less current maturities | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Derivative liabilities - long-term | ||||||||||||||||||||
| Future site restoration | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' (Deficit) Equity | ||||||||||||||||||||
| Preferred stock, par value $0.01 per share - authorized 1,000,000 shares; - 0- shares issued and outstanding | ||||||||||||||||||||
| Common stock, par value $0.01 per share, authorized 150,000,000 shares; 8,421,910 and 100,701,430 issued and outstanding at December 31, 2021 and 2022, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' (deficit) equity | ||||||||||||||||||||
| Total liabilities and stockholders' (deficit) equity | ||||||||||||||||||||
Loading...
